Evidence map›Paper›PMID 36662851›Full record

ArticleScience advances2023

ESPRESSO: Robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data.

Yuan Gao, Feng Wang, Robert Wang, Eric Kutschera, Yang Xu, Stephan Xie, Yuanyuan Wang, Kathryn E Kadash-Edmondson, Lan Lin, Yi Xing

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Role of alternative splicing in cancer progression.Irish journal of medical science · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yuan GaoCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-9510-6515
Feng WangCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0001-8346-4692
Robert WangCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0003-2614-5956
Eric KutscheraCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-2160-1820
Yang XuCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0001-8997-5995
Stephan XieCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-5248-7602
Yuanyuan WangCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Kathryn E Kadash-EdmondsonCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-1437-0147
Lan LinDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-9905-8928
Yi XingCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0001-9257-7613
Children's Hospital of Philadelphia · US

Funding

Training Program in Computational GenomicsT32HG000046 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI JUNHYONG KIM, Mingyao Li · 1999 to 2026
$9.5M
Targeting alternative splicing for TCR discovery in small cell carcinomasU01CA233074 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CROOKS, GAY M, WITTE, OWEN N. · 2018 to 2022
$4.1M
VARIATION AND REGULATION OF ALTERNATIVE SPLICING IN HUMAN TRANSCRIPTOMESR01GM088342 · NIGMS · UNIVERSITY OF IOWA · PI XING, YI · 2010 to 2020
$2.9M
Identification and cloning of neoantigen-specific T cells for GBM immunotherapyR01CA222695 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PRINS, ROBERT M, XING, YI · 2019 to 2023
$2.0M
Regulation and Function of RNA Editing in Human TranscriptomesR01GM121827 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIN, LAN · 2017 to 2021
$1.9M
Computational tools and resources to study alternative splicing and mRNA isoform variationR56HG012310 · NHGRI · CHILDREN'S HOSP OF PHILADELPHIA · PI XING, YI · 2022 to 2022
$569k
NCI NIH HHS R01 CA222695NCI NIH HHS U01 CA233074NHGRI NIH HHS R56 HG012310NHGRI NIH HHS T32 HG000046NIGMS NIH HHS R01 GM088342NIGMS NIH HHS R01 GM121827
6 · The paper itself

Abstract

Long-read RNA sequencing (RNA-seq) holds great potential for characterizing transcriptome variation and full-length transcript isoforms, but the relatively high error rate of current long-read sequencing platforms poses a major challenge. We present ESPRESSO, a computational tool for robust discovery and quantification of transcript isoforms from error-prone long reads. ESPRESSO jointly considers alignments of all long reads aligned to a gene and uses error profiles of individual reads to improve the identification of splice junctions and the discovery of their corresponding transcript isoforms. On both a synthetic spike-in RNA sample and human RNA samples, ESPRESSO outperforms multiple contemporary tools in not only transcript isoform discovery but also transcript isoform quantification. In total, we generated and analyzed ~1.1 billion nanopore RNA-seq reads covering 30 human tissue samples and three human cell lines. ESPRESSO and its companion dataset provide a useful resource for studying the RNA repertoire of eukaryotic transcriptomes.

Indexed as

RNATranscriptomeGene Expression ProfilingHumansProtein IsoformsRNA-SeqSequence Analysis, RNAProtein IsoformsRNA

Identifiers

PMID36662851
PMCPMC9858503
OpenAlexW4317553434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.